Bone marrow micronucleus frequencies in the rat after oral administration of cyclophosphamide, hexamethylphosphoramide or gemifloxacin for 2 and 28 days
Abstract
* Corresponding authors
a
AstraZeneca R&D, Alderley Park, Macclesfield, Cheshire, UK
E-mail:
ann.doherty@astrazeneca.com
Fax: +44 (0)1625 231281
Tel: +44 (0)1625 231285
Fetching data from CrossRef.
This may take some time to load.
Loading related content